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Abstract
Background: The incidence and mortality rates of cancer are increasing worldwide, particularly in the developing countries. Valid data 
are needed for measuring the cancer burden and making appropriate decisions toward cancer control. We evaluated the completeness of 
GHDWKUHJLVWU\ZLWKUHJDUGWRFDQFHUGHDWKLQ)DUV3URYLQFH,5RI,UDQ
Methods: We used data from three sources in Fars Province, including the national death registry (source 1), the follow-up data from 
the pathology-based cancer registry (source 2) and hospital based records (source 3) during 2004 – 2006. We used the capture-recapture 
PHWKRGDQGHVWLPDWHGXQGHUHVWLPDWLRQDQGWKHWUXHDJHVWDQGDUGL]HGPRUWDOLW\UDWH$605IRUFDQFHU:HXVHGORJOLQHDU//PRGHOLQJ
for statistical analysis. 
Result: :HREVHUYHGDQGFDQFHUGHDWKVLQVRXUFHVDQGUHVSHFWLYHO\$IWHUGDWDOLQNDJHZHHVWLPDWHGWKDWPRUWDOLW\
UHJLVWU\KDGDERXWXQGHUHVWLPDWLRQIRUFDQFHUGHDWK$IWHUDGMXVWPHQWIRUWKLVXQGHUHVWLPDWLRQUDWHWKH$605RIFDQFHULQWKH)DUV
3URYLQFHIRUDOOFDQFHUW\SHVLQFUHDVHGIURPSHU&,±WRSHU&,±DFFRXQWLQJ
IRU&,±FDQFHUGHDWKVDQQXDOO\
Conclusion: The mortality rate of cancer is considerably higher than the rates reported by the routine registry in Iran. Improvement in the 
validity and completeness of the mortality registry is needed to estimate the true mortality rate caused by cancer in Iran.
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Introduction
EI¿FLHQWFDQFHUDQGGHDWKUHJLVWUDWLRQV\VWHPVIRUPWKHIXQ-damental infrastructure of cancer control programs1 and 
provide important information for policy making, program 
planning and monitoring, resource allocation, and priority set-
ting.2 There is an absence of functional cancer registries in several 
low- and middle-income countries, including Iran.3,4 In addition to 
the cancer registry, data from the death registry could provide im-
portant information regarding the cancer control status. Although 
vital statistics and death registries exist in several developed and 
developing countries, low- and middle-income countries lack 
valid data on the causes of death.5,6 Therefore, the knowledge of 
distribution and determinants of death is lacking in developing 
countries.7 
Several methods exist for determining the validity of the causes 
of death in death registries; among these the “verbal autopsy” or 
systematic retrospective inquiry of family members about the 
symptoms and signs of illness prior to death has been commonly 
used. In addition, data linkage between the cancer registry and 
external databases in the UK and US has allowed researchers to 
evaluate the validity and accuracy of the cancer death records.8,9 
A few studies have evaluated the completeness or coverage 
of death registration in total, and based on different causes of 
death.5,10,11 In spite of several cancer registry activities in Iran,12–17 
only Golestan Province cancer registry has been sustained for a 
reasonable time and was published in the 10th revision of IARC 
monograph “Cancer in Five Continents” in 2013.18 Golestan prov-
ince is located at the western end of Central Asian Esophageal 
Cancer Belt, an area that extends from the Caspian Sea through 
Central Asia and Mongolia to northern China.19 This registry cov-
ers a small population in the northern Iran and the results from 
this registry cannot represent the Iranian population. Therefore, 
due to lack of validated population-based cancer registries in Iran, 
cancer statistics are overshadowed by several uncertainties; con-
sequently, the true incidence and mortality rate of cancer remain 
unknown.4  
Application of the capture–recapture method was suggested as 
the standard approach to evaluate the completeness of registries 
and estimate the true incidence rates of diseases such as cancer.20,21 
However, this method has not yet been used to estimate the com-
pleteness of the mortality registry. In this study, we used a three-
source capture–recapture method and studied the completeness 
of the death registry along with an estimation of the true mortal-
ity rates of cancer, in total and for common cancer types, in Fars 
Province.
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Materials and Methods
This study was conducted in Fars Province, located in southern 
Iran; a large area with a population of 4,336,878. The 10 most 
common cancers, including stomach, esophageal, colorectal, 
lung, bladder, prostate, breast, ovarian, cervical, and endometrial 
cancers were selected from different databases in Fars province 
including 1) Mortality Registry, 2) Pathology-Based Cancer Reg-
istry and 3) Hospital Records.
Three data sources were selected to use the capture–recapture 
method and estimate the true number of cancer deaths and the 
mortality rate for different cancer types in a population of 13,309. 
Because we needed at least three independent data sources to ap-
ply the capture–recapture method, we used data from the Fars 
province death registry and two additional independent data 
sources that accounted for cancer deaths in the province. The ad-
ditional sources included the cancer mortality data created from 
the follow-up of pathology-based cancer registry data and follow-
up of the hospital cancer records. The subsequent paragraph de-
scribes the three data sources in detail.
Fars Province Death Registry
The Deputy of Health in the Shiraz University of Medical Sci-
ence compiles the death records and information on the causes of 
death in the entire Fars Province with 1941 cases. Subsequently, 
data are sent to the Ministry of Health of Iran to report the national 
FDXVHVSHFL¿FPRUWDOLW\UDWHV,QWKHFXUUHQWVWXG\ZHXVHGGDWD
from 2004 to 2006, since the mortality rate has been published in 
this period and comprehensive data were available for analysis. 
The death registry of Fars Province collected data from 21 cities, 
including the capital city of Shiraz. The registry collects differ-
ent variables including sex, date of death, causes of death, and 
place of residence. The mortality data are then coded based on the 
cause. We restricted our analyses to the death records coded as 
cancer death. We selected the 10 most common cancers; however, 
ZHH[FOXGHGKHPDWRORJLFPDOLJQDQFLHVEHFDXVHRIWKHGLI¿FXOWLHV
in specifying cancer types in the death registry. 
Follow-up of cancer patients from a pathology-based cancer registry
The pathology-based cancer registry was established in Fars 
Province in 1998. It collects cancer data from patients who are 
UHIHUUHGIRUPLFURVFRSLFYHUL¿FDWLRQIURPGLIIHUHQWODERUDWRULHVLQ
the province. The Shiraz cancer registry is not a population-based 
registry and is restricted to cases undergoing surgery. Tumor tis-
sues or biopsies are sent to the pathology department. The Shiraz 
pathology registry records approximately 5000 cancer cases from 
the entire province each year. We obtained electronic data from 
the Fars province cancer registry between 2001 and 2006. The 
cancer registry included different types of cancers along with the 
patients’ contact information. We contacted patients or their next-
of-kin and obtained information on the vital status of the patients. 
Those who had died during 2004 – 2006 were included in a data-
base and used as a data source for the capture–recapture method. 
Follow-up of cancer patients from the hospital records
The Shiraz cancer registry is a pathology-based registry and pa-
tients with an advanced tumor who are generally diagnosed clini-
cally may not be registered in this cancer registry. Therefore, we 
performed a survey and collected cancer cases that were hospital-
ized with a cancer diagnosis between 2001 and 2006 in different 
hospitals of the province. First, we contacted all hospitals in Fars 
province and collected data from 16 hospitals that had diagnostic 
or treatment facility for cancer patients including both private and 
governmental hospitals from different cities of Shiraz. Informa-
tion on 10 common cancers was manually collected from the hos-
pital records. After excluding the duplicates, we followed up these 
patients through telephone interviews with the patients or their 
next-of-kin. Those who died of cancer between 2004 and 2006 
formed the third data source for the capture–recapture analyses. 
Statistical Analysis 
Following the elimination of duplicates from each of the three 
data sources and patients who resided outside of Fars province, 
ZH SHUIRUPHG D GDWD OLQNDJH XVLQJ WKH 0LFURVRIW 2I¿FH ([-
cel. The criteria for linkage was sharing six variables including 
names,  family name, father’s name, age, date of birth, and place 
of residence. In Farsi, names, family name or father names may 
be spelled slightly different in various databases. For names and 
family names that had small differences, we considered the age, 
date of birth or place of residence and if the information for the 
above mentioned variables were similar, we considered them as 
a unique patient and merged their information. We performed 
statistical analyses for the 10 most common cancers including 
stomach, esophageal, colorectal, lung, bladder, prostate, breast, 
ovarian, cervical, and endometrial cancers, as well as all cancers 
combined.  
The capture-recapture method and log-linear modeling were 
used to estimate the total number of mortality rates of common 
cancers in Fars Province. The use of the capture–recapture meth-
od requires two or three data sources. Two important assumptions 
need to be met prior to use of this method, including indepen-
dence of the data sources and equal accessibility to the data. How-
ever, for our statistical analyses we used log-liner modeling in 
which these assumptions are not essential.22 Observed numbers of 
separate or combined sources were entered in the model for mak-
ing capture- recapture model. Source dependence was modeled 
by adding the interaction term to the model. In total, we run eight 
models based on the three data sources  (Table 1).
$FRQ¿GHQFH LQWHUYDO &, IRU WKH HVWLPDWHG QXPEHU RI FDVHV
ZDVFRPSXWHGYLDWKHSUR¿OHOLNHOLKRRGPHWKRG%D\VLDQ (BIC) 
and Akaike (AIC) Information Criterion were used for model 
selection. For the log-linear model the value for this criterion is 
AIC, and the model with the smallest AIC is selected as the best 
model.23,24
Following the estimation of the under-reported rate of cancer 
GHDWK LQ WRWDO DQG LQ WKH¿YH\HDUDJH VWUDWDZHHVWLPDWHG WKH
corrected mortality rates for the all types of cancers and common 
cancers. We used the age distribution of the world standard pop-
ulation to estimate the age standardized mortality rates. STATA 
software (version 9) was used for statistical analyses.
 
Result
We observed 1969 cancer deaths recorded in the Fars Province 
death registry (source 1) between 2004 and 2006. After removing 
the duplicates, an overall 1941 cancer deaths from mortality reg-
istry database remained for analysis. In addition, after data link-
age and follow-up of the patients from pathology-based cancer 
registry (Source 2) and hospital records (Source 3), and exclud-
ing the patients who had no contact information, resided in other 
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Model Number Formula Explanation
Model 1 Pijk O+Ois1Ojs2Oks3 All the source independently in model
Model 2 Pijk O+Ois1Ojs2Oks3Oiks1s3 All the source independently in model and interaction of s1 and s3
Model 3 Pijk O+Ois1Ojs2Oks3Oijs1s2 All the source independently in model and interaction of s1 and s2
Model 4 Pijk O+Ois1Ojs2Oks3Oijs3s2 All the source independently in model and interaction of s3 and s2
Model 5 Pijk O+Ois1Ojs2Oks3Oijs1s2Oiks1s3 All the source independently in model and interaction of s1 & s2 and s1&s3
Model 6 Pijk O+Ois1Ojs2Oks3Oijs3s2Oiks1s3 All the source independently in model and interaction of s3 & s2 and s1&s3
Model 7 Pijk O+Ois1Ojs2Oks3Oijs3s2Oiks1s2 All the source independently in model and interaction of s3 &s2 and s1&s2
Model 8 Pijk O+Ois1Ojs2Oks3Oijs3s2Oiks1s2Oiks1s3 All the source independently in model and interaction of s3 &s2 and s1&s2
Table 1. Source dependence was modeled by adding the interaction term to the model
Figure 1. Flowchart of the record linkage from the data sources for using capture-recapture method and evaluate true mortality rate of cancer in Fars 
Province in the southern Iran in 2004–2006. Source 1: Mortality registry; Source 2: Follow-up of pathology based cancer registry; Source 3: Follow-up 
of Hospital data
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provinces etc., we found 480 and 355 cancer deaths from Source 2 
and Source 3, respectively (Figure 1). The response rate of cancer 
patients or their relatives was 26%. Figure 1 presents the details 
RIWKHGDWDÀRZIURPWKHWKUHHGDWDVRXUFHVDQGWKH9HQQGLDJUDP
(Figure 2) shows the share of data from each data sources. Finally 
a linkage of the data from the three data sources provided 2232 
cases of cancer death for statistical analysis (Table 2). The major-
ity of the patients were men (62.1%), and most of them were 50 
years or older (58.6%). In addition, 904 (40.50) cases were from 
Shiraz City and 1324 (59.32%) were from other cities (Table 2). 
We present the results of eight models that estimated the true num-
ber of cancer deaths from the three data sources in Fars Province 
in Table 3. Based on the 4th model, which was assumed to be the 
optimal model in this data that showed the lowest AIC (8.5) and 
BIC (-2.62) measurements, we estimated that 3309 cancer deaths 
have occurred in Fars Province between 2004 and 2006 (95% 
&,±7DEOH7KLV¿QGLQJLQGLFDWHVFRYHUDJH
and 42% underestimation of the cancer death in the Fars prov-
ince death registry (Table 4). ASMR for all cancer types increased 
from 44.8 per 100,000 (95% CI 42.8 – 46.7) which was reported 
by mortality registry to 76.3 per 100,000 (95% CI 73.3 – 78.9) 
which was estimated in this study. Based on the corrected estima-
tion, the highest mortality rates were observed for lung (ASMR 
25 per 100,000) and stomach (ASMR 23.5 per 100,000) cancers 
and the lowest rates were observed for colon (3.0 per 100,000) 
and esophageal (2.7 per 100,000) cancers.
Figure 2. Venn diagram, presenting number of cancer death observed in the three data sources independently and in common with the other in Fars 
province in the southern Iran in 2004–2006
Data Source  OverallNumber
Sex*, Number (%) Age Group (years)*, Number (%)  Place of residence*,Number (%)
Male Female 25–0 50–26 65–51 Up to 65 Shiraz City Other cities
Source1 1528 989 (64.7) 539 (35.3) 32 (2.0) 204 (13.3) 337 (22) 950 (62.1) 530 (34.6) 997 (65.2)
Source2 137 75 (54.7) 61 (44.5) 3 (2.2) 16 (11.7) 16 (11.7) 100 (73.0) 73 (53.3) 62 (45.7)
Source3 98 54 (55.1) 43 (43.9) 3 (3.1) 12 (12.2) 21 (21.4) 45 (45.9) 57 (58.2) 41 (41.8)
Source1&2 212 142 (67.0) 69 (32.6) 3 (1.4) 34 (16.0) 51 (24.1) 123 (58.0) 95 (44.8) 115 (54.2)
Source1&3 126 67 (53.2) 59 (46.8) 1 (0.8) 30 (23.8) 31 (24.6) 57 (45.2) 74 (58.7) 52 (41.3)
Source2&3 56 33 (58.9) 21 (37.5) 0 (0.0) 13 (23.2) 22 (39.3) 11 (19.6) 39 (69.6) 17 (30.4)
Source1,2&3 75 26 (34.7) 49 (65.3) 2 (2.7) 20 (26.7) 23 (30.6) 30 (40.0) 35 (46.6) 40 (53.3)
 All Sources
Combined 2232 1386 (62.1) 841 (37.7) 45 (2.0) 329 (14.7) 501 (22.5) 1316 (59.0) 904 (40.5) 1324 (59.3)
*Because of missing information on age, sex, and residential places, the sum of percentages does not add up to 100%.
Table 2. Characteristics of patients who died of cancer between 2004 and 2006 in Fars Province, reported from the mortality registry (source1), 
and collected from the follow-up of the pathology-based cancer registry (source2) and hospital records (source3) in overall and by sex , age and 
the place of residence
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Model 8Model 7Model 6Model 5Model 4Model 3Model 2Model 1Observed No. of death
152815281528148315281455145514521528Source 1
137140137137144170137159137Source 2
98989798939812911298Source 3
212209212257205252285266212Source 1&2
126126127171131199168188126Source 1&3
565357565423252156Source 2&3
757874307735333575Source 1, 2&3
1029118898724010777167008640None of the sources 
3261
(2863–3908)
3420
(3140–3786)
3219
(3023–3463)
2472
(2397–2579)
3309
(3151–3293)
2948
(2797–3139)
2932
(2802–089)
3096 
(2975–3236)2232
Total estimated 
number(95% CI)
8.898.678.6118.798.524.9624.1525.29AIC
4.17 e -14-1.46-1.9169.38-2.62112.63106.93115.00BIC
Model 1: Pijk O+Ois1Ojs2Oks3 : all the source independently in model
Model 2: Pijk O+Ois1Ojs2Oks3Oiks1s3 : all the source independently in model and interaction of s1 and s3
Model 3: Pijk O+Ois1Ojs2Oks3Oijs1s2 :all the source independently in model and interaction of s1 and s2
Model 4: Pijk O+Ois1Ojs2Oks3Oijs3s2 :all the source independently in model and interaction of s3 and s2
Model 5: Pijk O+Ois1Ojs2Oks3Oijs1s2Oiks1s3 :all the source independently in model and interaction of s1 & s2 and s1&s3
Model 6: Pijk O+Ois1Ojs2Oks3Oijs3s2Oiks1s3 :all the source independently in model and interaction of s3 & s2 and s1&s3
Model 7: Pijk O+Ois1Ojs2Oks3Oijs3s2Oiks1s2 :all the source independently in model and interaction of s3 &s2 and s1&s2
Model 8:Pijk O+Ois1Ojs2Oks3Oijs3s2Oiks1s2Oiks1s3 :all the source independently in model and interaction of s3 &s2 and s1&s2
Table 3. Observed and estimated numbers of cancer deaths between 2004 and 2006 in Fars province, using three-source captures recapture method.
Underreporting 
rate %
EstimatedObserved
Cancer
ASMR/100,000MR/100,000N. of deathASMR/100,000MR/100,000N. of death
4276.3 (73.3–78.9)76.2330944.8 (42.8–46.7)44.71941All Cancer 
74.9 (71.3–78.5)74.8165155.5 (52.4–58.6)55.511224    Male
80.6 (76.8–84.4)80.5171833.6 (31.1–36)33.58716    Female
605.2 (4.5–5.9)5.22262.1 (1.6–2.5)2.00790Bladder Cancer
9.6 (8.3–10.9)9.52113.5 ( 2.7–4.3)3.4977   Male
1.1 (0.6–1.5)1.07230.60 (0.30– 0.90)0.6013   Female
353.0 (2.5–3.5)2.91302.0 (1.5–2.4)1.9585Colon Cancer
4.1 (3.2–4.9)4.08902.6 (1.9–3.3)2.5857      Male
1.9 (1.3–2.5)1.9411.3 (0.8–1.8)1.3128      Female
336.9 (0.61–0.77)6.9300.5 (0.3–0.7)0.4620Rectal Cancer
0.9 (0.5–0.12)0.86110.4 (0.1–0.7)0.409      Male
0.9 (0.5–0.13)0.89190.5 (0.2–0.8)0.5111      Female
442.7 (2.2–3.2)3.71181.5 (1.2–1.9)1.5666Esophageal Cancer
3.0 (2.3–3.8)3.03671.9 (1.3–2.4)1.8541      Male
5.9 (4.8–6.9)5.81251.2 (0.7–1.6)1.1725      Female
4825 (23.5–26.5)25.01108512.8 (11.7–13.9)12.79555Lung Cancer
31.4 (29–33.7)31.369217.8 (16.1–19.6)17.82393      Male
24.9 (22.7–27)24.85307.6 (6.4–8.7)7.55161      Female
3023.5 (22.1–25)23.5102016.3 (15.1–17.5)16.32708Stomach Cancer
48.4 (45.5–51.3)48.3106720.5 (18.7–22.4)20.54453      Male
16.2 (14.5–17.9)16.234612.0 (10.5–17.5)11.9255      Female
421.3 (0.8–1.8)1.31280.8 (0.4–0.11)0.7516Ovarian Cancer**
2710.6 (9.3–12.0)10.62277.7 (6.6–8.9)7.73165Breast Cancer**
505.6 (4.6 –6.6)5.61202.8 (2.1–3.5)2.7659Endometrial Cancer**
3214.1 (12.5–15.7)14.13119.6 (8.3–10.9)9.56211Prostate Cancer**
*MR: Crude Mortality Rate; ASMR: Age Standardized Mortality Rate; ** Breast cancer was restricted to women
Table 4. Observed and estimated mortality rates of cancer in overall and for common cancers in Fars provinces in the southern part of Iran in 
2004–2006.
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Discussion
We used the capture–recapture method and discovered that the 
current death registry underestimates the true mortality rate of 
cancer by about 40% in Fars Province, I. R. of Iran. After correc-
tion of the underestimation rate, cancer mortality rate increased 
from 44.8 per 100,000 to 76.3 per 100,000. 
We used the log-linear method for statistical analyses, in which 
the data sources should not subset from one another and at least 
three data sources are available for analyses.25 Although the three 
data sources were collected independently, the pathology-based 
cancer registry was thought to be a subset of the hospital records 
and these two data sources may not be assumed as two indepen-
dent databases. However, this is not true for many of the cancers 
in the developing countries, where some of the patients are di-
agnosed at an advanced stage and are not operated upon or sent 
for histo-pathological diagnosis. Therefore, the three data sources 
could be seen as independent data sources that have their own spe-
FL¿FGDWDZKLFKLVQRWVKDUHGE\WKHRWKHUVRXUFHV
We followed cancer patients who were diagnosed between 2001 
and 2006 and selected the deaths that occurred between 2004 and 
2006. This has led to a limited estimation of cancer deaths in the 
generated data sources, therefore provided limited power for the 
appropriate estimations in our model. It may then, cause some in-
VWDELOLW\LQWKHHVWLPDWHG¿JXUHVSURYLGHGE\RXUVWDWLVWLFDOPRGHO
For example, the numbers of deaths resulting from lung and stom-
ach cancers that are diagnosed at a very advanced stage and have 
a poor prognosis were proportionally higher in the death registries 
compared with the pathology and hospital sources. However, our 
estimates for the combined cancer types stem from a reasonable 
power and should be close to the actual numbers. According to the 
Globocan 2008, for all cancers, the age standardized mortality rate 
was 80.5 per 100,000 which is close to the estimation provided 
from this (76.3 per 100,000).26 
Lung cancer is usually diagnosed in the advanced stages and is 
a common cause of cancer death worldwide. It is generally diag-
nosed clinically and is not accounted for by the pathology regis-
tries. In an audit of cancer registries in Iran, lung cancer had the 
highest underestimated rate (approximately 80%) in the pathol-
ogy-based cancer registry.42XU UHVXOWV VXSSRUWHG WKHVH¿QGLQJV
and we found a high underestimation for lung cancer, although 
lung cancer was not the most common cancer among the Iranian 
population.27 Based on our results, the true incidence and mortality 
rate seems to be much higher than that reported by the pathology-
based cancer registry and national death registry.28
We found a small number of deaths caused by rectal cancer in the 
GHDWKUHJLVWU\ZKLFKFRXOGEHEHFDXVHRIWKHPLVFODVVL¿FDWLRQRI
UHFWDODQGFRORQFDQFHULQWKHGHDWKFHUWL¿FDWHV0DQ\SDWLHQWVDQG
their next-of-kin are unaware of the exact diagnosis of cancer and 
UHFWDORUFRORQFDQFHUPD\EHHDVLO\PLVFODVVL¿HGZKHQWKHSK\VL-
FLDQLVVXHVWKHFHUWL¿FDWH$OWKRXJKWKHVHQVLWLYLW\RIUHFWDOFDQFHU
was 5% in the death registry, when we combined the colon and 
rectal cancers and analyzed them together as colorectal cancer, the 
sensitivity reached 66%. The sensitivity of the death registry was 
also low for colorectal cancer in the Virginia death registry; it was 
reported to be approximately 60% for colorectal cancer.32
Overall, the sensitivity of our system in the diagnosis of all 
cancer mortality was very low (58%); it was considerably lower 
than the rate reported in the Netherlands (98.3%),20 and Ger-
many (95.5%).33 When we estimated the true number of deaths 
caused by cancer, the number of cancers increased from 1941 
to 3309, indicating that the true cancer mortality is much higher 
than the rate reported by the mortality registry. An analysis of 
data from a cohort study in Korea showed that the sensitiv-
ity of the death registry was high.34 The overall sensitivity of 
cancer registries in Gambia was 50.3%,35 whereas the overall 
under-registration of deaths was 9% in Thailand.6 However, the 
completeness of death registration in Brazil varies from 72% 
to 80% in the northeast regions, compared with 85% to 90% in 
the Southeast and Center-West regions, and 94% to 97% in the 
wealthier Southern region.5
Many developing countries lack well-functioning cancer and 
death registration systems.36 According to the World Health Orga-
nization, approximately 80% of NCD deaths (29 million) occur in 
low- and middle-income countries.37 Developing countries need 
to improve the management of their death registration systems 
and provide valid statistics for causes of death and important tools 
for the monitoring of public health interventions. 
Although the capture- recapture method has been widely used 
for estimation of different disease rates, to the best of our knowl-
edge, this method has not been previously used for estimation of 
cancer death. In addition to the data from mortality registry, we 
created two data sources for cancer death through active follow-
up of the cancer patients and applied capture recapture analyses 
for estimation of true cancer mortality rate and evaluation of the 
quality of mortality registry vis-à-vis cancer death. In spite of the 
strength of this study, it faces a few limitations. Because there was 
QRXQLTXHLGHQWL¿FDWLRQQXPEHUZHXVHGSUREDELOLVWLFDSSURDFK
for data linkage. We used six variables including patient name, 
family name, father’s name, age, date of birth, and place of resi-
dence for data linkage and removed the duplicates. The Persian 
names may be spelled slightly differently in the sources we used 
IRU GDWD OLQNDJH:HPDQXDOO\¿[HG WKH HUURUV DQGGLIIHUHQFHV
However, in a few cases (less than 5%), we failed to identify the 
information and detect the duplicates. Because of our rigorous ap-
proach, the impact of this limitation on the results of this study 
should be minimal. 
In conclusion, we observed considerable underestimation in 
the cancer mortality rate among the Iranian death registry. Ef-
forts to improve the validity of information and coverage of the 
death registry for cancer mortality are necessary. A regular audit 
in addition to monitoring and evaluation activities should be an 
essential part of the death registration system to ensure validity 
DQGFRPSOHWHQHVVRIGHDWKDVZHOODVDFFXUDF\RIFDVHVSHFL¿F
mortality rates. In addition, an update of the guidelines for issu-
LQJWKHGHDWKFHUWL¿FDWHVDVZHOODVWUDLQLQJRIPHGLFDOGRFWRUV
and other health professionals who are involved in issuing the 
GHDWKFHUWL¿FDWHPD\LPSURYHWKHVWDQGDUGRIWKHGHDWKUHJLVWU\
in I. R. of Iran. 
&RQÀLFWVRI,QWHUHVWDQG$FNQRZOHGJPHQW
$OODXWKRUVGHFODUHQRFRQÀLFWRILQWHUHVWV7KLVSURMHFWZDVFRQ-
ducted as a Master’s thesis in Kerman University of Medical Sci-
ences with a grant from the Cancer Research Center, Cancer Insti-
tute of Iran, Tehran University of Medical Sciences.
Unfortunately one of our co-authors, Dr. Eshagh Dortaj, who 
contributed completely in this research died before this manuscript 
could be published. We would like to honor his memory.    
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